Cite
HARVARD Citation
Yamasaki, K. et al. (2022). Adalimumab in Japanese patients with active ulcers of pyoderma gangrenosum: Final analysis of a 52‐week phase 3 open‐label study. Journal of dermatology. 49 (5), pp. 479-487. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Yamasaki, K. et al. (2022). Adalimumab in Japanese patients with active ulcers of pyoderma gangrenosum: Final analysis of a 52‐week phase 3 open‐label study. Journal of dermatology. 49 (5), pp. 479-487. [Online].